| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |